Asset Comparison and Correlation

Assuming 30 trading days horizon, SK Innovation is expected to under-perform the DOC IMBITUBA. But the stock apears to be less risky and, when comparing its historical volatility, SK Innovation is 2.08 times less risky than DOC IMBITUBA. The stock trades about -0.09 of its potential returns per unit of risk. The DOC IMBITUBAPN is currently generating about 1.07 of returns per unit of risk over similar time horizon. If you would invest  49.00  in DOC IMBITUBAPN on April 25, 2013 and sell it today you would earn a total of  2.00  from holding DOC IMBITUBAPN or generate 4.08% return on investment over 30 days.